Bitrobius Genetics
Industry Sector
Biotechnology
Deal Type
Early Stage
Date
2021
Website Link
http://www.bitrobius.com/Bitrobius is a start-up biotechnology company developing a synthetic gene transfer technology for use in the research & development, manufacture and delivery of cell and gene therapies and vaccines.
Why we like the business
Cell and gene therapy is an emerging and fast-growing area of biotechnology and drug development. Bitrobius has a very novel platform technology to increase the efficiency of gene transfer that could be applied to many areas of cell and gene therapy with multiple commercialisation routes.